US Stocks Rated 7.3–7.4 out of 10 for Quality
The 100 US equities scoring 7.3–7.4 on CirclFi's Quality of Company score, each with its 13-model median fair value and implied upside. Recomputed after every US market close.
1,274 of the 3,804 US equities CirclFi can currently value (33.5%) trade below the median fair value of their active models as of , and 2,530 (66.5%) trade above it. For the median US equity that fair value sits 23.1% below the current share price, and 56 companies score 9.5 or higher for fundamental quality. The highest-quality name currently trading at a discount is Gilead Sciences, Inc. (GILD), at 9.7/10 quality with a $151.25 median fair value, 3.4% above its $146.34 price.
Two counts appear on this page. CirclFi publishes a page for all 5,877 US equities it covers, and 3,804 of those have enough filing history for at least two of the 13 models to return a usable fair value. Only that second group can be called undervalued or overvalued, so it is the denominator above; the remaining 2,073 are recent listings, shell companies and issuers with incomplete XBRL, and they are reported as unvalued rather than counted as fairly valued.
Full market breakdown by sector and model agreement: US Market Valuation Index → · Ranked screens: stock lists →
All 5,877 stocks. 13 models each. One live terminal.
Sort by any metric, filter by industry, export to CSV. The same analytical depth Wall Street pays thousands for.
Bloomberg: ~$2,000/mo · CirclFi: from $39/mo
Start Your Edge — $39/mo